[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

NEO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.95

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.16

Price

8.01

Target Price

13.61

Analyst Recom

2.29

Performance Q

-39.21

Upside

-467.5%

Beta

1.73

Ticker: NEO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	NEO	8.27	0.12	999.99	9526
2026-03-18	NEO	8.01	0.12	999.99	9526
2026-03-19	NEO	8.19	0.12	0.02	9513
2026-03-20	NEO	7.94	0.12	0.38	9456
2026-03-23	NEO	8.11	0.12	0.00	9391
2026-03-24	NEO	7.87	0.12	0.80	9652
2026-03-25	NEO	7.78	0.12	0.00	9673
2026-03-26	NEO	7.75	0.12	0.00	9563
2026-03-27	NEO	7.18	0.12	0.03	9558
2026-03-30	NEO	7.2	0.11	999.99	10689
2026-03-31	NEO	7.43	0.11	1.00	10689
2026-04-01	NEO	7.75	0.11	0.00	10688
2026-04-02	NEO	7.99	0.11	0.25	10691
2026-04-06	NEO	8.05	0.11	0.00	10694
2026-04-07	NEO	8.05	0.11	7.07	10713
2026-04-08	NEO	8.22	0.12	0.67	10829
2026-04-09	NEO	7.96	0.12	49.00	10832
2026-04-10	NEO	7.68	0.12	0.33	10876
2026-04-13	NEO	8	0.12	1.00	10877
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	NEO	8.27	0.0	-	0.16
2026-03-18	NEO	8.00	0.0	-	0.16
2026-03-19	NEO	8.19	0.0	-	0.16
2026-03-20	NEO	7.95	0.0	-	0.16
2026-03-23	NEO	8.09	0.0	-	0.16
2026-03-24	NEO	7.86	0.0	-	0.16
2026-03-25	NEO	7.77	0.0	-	0.16
2026-03-26	NEO	7.75	0.0	-	0.16
2026-03-27	NEO	7.19	0.0	-	0.16
2026-03-30	NEO	7.20	0.0	-	0.16
2026-03-31	NEO	7.43	0.0	-	0.16
2026-04-01	NEO	7.76	0.0	-	0.16
2026-04-02	NEO	7.99	0.0	-	0.16
2026-04-06	NEO	8.02	0.0	-	0.16
2026-04-07	NEO	8.05	0.0	-	0.16
2026-04-08	NEO	8.23	0.0	-	0.16
2026-04-09	NEO	7.94	0.0	-	0.16
2026-04-10	NEO	7.68	0.0	-	0.16
2026-04-13	NEO	8.01	0.0	-	0.16
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	NEO	-2.22	6.71	6.61
2026-03-18	NEO	-2.22	6.71	6.61
2026-03-19	NEO	-2.22	6.71	6.61
2026-03-20	NEO	-2.22	6.71	6.61
2026-03-23	NEO	-2.22	6.71	6.61
2026-03-24	NEO	-2.22	6.71	6.61
2026-03-25	NEO	-2.22	6.71	6.54
2026-03-26	NEO	-2.22	6.71	6.54
2026-03-27	NEO	-2.22	6.71	6.54
2026-03-30	NEO	-2.22	6.71	6.54
2026-03-31	NEO	-2.22	6.71	6.54
2026-04-01	NEO	-2.22	6.71	6.54
2026-04-02	NEO	-2.22	6.71	6.54
2026-04-06	NEO	-2.22	6.67	6.54
2026-04-07	NEO	-2.22	6.67	6.54
2026-04-08	NEO	-2.22	6.67	6.54
2026-04-09	NEO	-2.22	6.67	6.54
2026-04-10	NEO	-2.22	6.67	6.54
2026-04-13	NEO	-2.22	6.65	5.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.04

Insider Transactions

-2.22

Institutional Transactions

6.65

Beta

1.73

Average Sales Estimate Current Quarter

184

Average Sales Estimate Next Quarter

196

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

85.4

Max Drawdown 5-Year %

-90.8

Target Price

13.61

P/E

Forward P/E

25.15

PEG

0.46

P/S

1.43

P/B

1.23

P/Free Cash Flow

EPS

-0.84

Average EPS Est. Cur. Y

0.16

EPS Next Y. (Est.)

0.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.85

Relative Volume

1.19

Return on Equity vs Sector %

-40.2

Return on Equity vs Industry %

-23.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]

◆ NEO Healthcare

$8.00

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

4/15

Valuation

15/20

TP/AR

3/10

Options

7/10

RSI

44.3

Range 1M

57.6%

Sup Dist

7.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

21/30

Estimates

4/20

Inst/Vol

7/15

Options

5/10

EPS Yr

43.4%

EPS NY

84.9%

52W%

35.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +48.6% upside

Quality

5/30

Valuation

15/30

Growth

18/25

Stability

8/10

LT Trend

0/5

Upside

+48.6%

Quality

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2500

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

[News_NEO _Stock]

stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today

news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance

stock history NEO – NeoGenomics, Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y